A look at vitamins D, B and A in alopecia areata

Alopecia areata (AA) is an autoimmune disease that leads to hair loss. While the specific cause remains unknown, various factors, including low levels of certain vitamins and minerals, have been implicated in its pathogenesis. This article focuses on the role of Vitamin D and B in AA, as recent findings have shed some light on their potential contribution to the disease process.

Vitamin D in Alopecia Areata: The role of Vitamin D in AA has been widely researched, though it is still poorly understood. Notably however, Vitamin D and its receptor (VDR) play critical roles in the hair growth cycle. The dysfunction of VDR has been linked to the loss of hair follicles, as evidenced by tissue culture studies and observations in patients with type II vitamin D-dependent rickets. These patients have normal hair at birth but later lose it entirely.

In AA, lower levels of VDR have been reported both in serum and scalp tissue. Despite this, genetic VDR polymorphisms, which could potentially contribute to the risk of developing AA, have not been demonstrated in studies. However, there is a consensus on the correlation of lower serum Vitamin D levels with increased AA severity. Several studies from different laboratories have shown reduced vitamin D is present in the serum of patients with AA. In one published article, low serum levels of Vitamin D (14.03 ± 8.09 ng/mL) were found in 79.6% in AA patients as compared to controls.

While our understanding of Vitamin D’s precise role in AA remains limited, its deficiency, coupled with decreased VDR levels, points to the possibility of Vitamin D playing a part in AA pathogenesis.

Vitamin B in Alopecia Areata: The role of Vitamin B in AA, particularly Biotin (B7) and Folate (B9), has been explored, although the studies remain sparse and contradictory. Nevertheless, deficiencies in these vitamins have been associated with hair loss and AA.

Interestingly, a study suggested a role of low red blood cell folate in the risk for AA development and its progression. Furthermore, AA patients have shown a higher frequency of genetic polymorphisms in the enzyme methylenetetrahydrofolate reductase (MTHFR), a key regulator of folate metabolism and homocysteine levels. These polymorphisms have also been associated with other autoimmune diseases like multiple sclerosis and systemic lupus erythematosus, suggesting a common link.

Other micronutrients have been examined in AA in a very limited way, including vitamin B12. The articles indicate no significant difference in B12 in AA patients. However, the evidence remains insufficient to draw any concrete conclusions regarding the role of B12 and other vitamins in AA.

Vitamin A: Vitamin A comprises a family of compounds, each possessing a core backbone and a modified side-chain, such as a hydroxyl group (retinol) or a carboxylic acid group (retinoic acid). It is not considered an antioxidant, but it is capable of influencing immune responses. For instance, retinoic acid has been shown to enhance T-cell proliferation and the antigen-presenting capacity of dendritic cells, inhibit B-cell proliferation, and maintain gut immune privilege.

Recent studies have documented an upregulation of genes involved in retinoid metabolism in AA patch biopsies from human subjects and in the AA mouse model. Intriguingly, the scientists observed that mice fed with high levels of vitamin A developed an earlier onset of disease. In contrast, those that did not receive vitamin A supplements experienced the most severe form of the disease. These findings align with those of Suo and colleagues, who found a dose-dependent role for vitamin A in starting the anagen hair cycle in mice, which might increase follicle susceptibility to autoimmune destruction. These observations suggest an optimized level of vitamin A might exist, implying that both deficiency and excess of vitamin A might favor the development and progression of AA. This complex relationship between vitamin A and AA illustrates the careful balance that must be struck in micronutrient regulation for optimal hair health.

A Threshold Hypothesis for Micronutrients and Alopecia Areata: Kantor and colleagues proposed an intriguing “threshold hypothesis,” wherein patients with mild hereditary susceptibility to AA might have a micronutrient level threshold. Below this level, the disease could develop, whereas patients with high hereditary susceptibility might develop AA regardless of their micronutrient status. In this hypothesis, sub-optimal micronutrients could lead to disease through aberrant immune cell function, DNA synthesis, and oxidative stress, a pathway that seems plausible given the documented deficiencies of certain vitamins in AA patients.

Conclusion: While the complexity of AA suggests a multifactorial etiology, vitamins D and B, along with other micronutrients, could significantly contribute to the development and progression of this disease. Future studies are needed to decipher the precise roles these nutrients play in AA, potentially leading to new diagnostic and therapeutic strategies. It would also be beneficial to investigate the potential synergistic effects of multiple nutrient deficiencies in AA and whether supplementation could help manage or prevent this debilitating condition.

Bibliography